Martin Fan
Stock Analyst at Wedbush
(4.87)
# 64
Out of 5,150 analysts
19
Total ratings
77.78%
Success rate
60.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZURA Zura Bio | Initiates: Outperform | $15 | $6.99 | +114.59% | 1 | Feb 9, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Outperform | $42 → $45 | $34.99 | +28.61% | 2 | Jan 13, 2026 | |
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $25.82 | +74.28% | 3 | Dec 22, 2025 | |
| VOR Vor Biopharma | Assumes: Neutral | $9 | $15.05 | -40.20% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.15 | -67.48% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $60.55 | -17.42% | 5 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $3.82 | +57.07% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $5.46 | +321.25% | 2 | Oct 17, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $7.87 | +382.85% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $3.10 | +158.06% | 1 | May 28, 2025 |
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $6.99
Upside: +114.59%
Oruka Therapeutics
Jan 13, 2026
Maintains: Outperform
Price Target: $42 → $45
Current: $34.99
Upside: +28.61%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $25.82
Upside: +74.28%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $15.05
Upside: -40.20%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.15
Upside: -67.48%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $60.55
Upside: -17.42%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $3.82
Upside: +57.07%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $5.46
Upside: +321.25%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $7.87
Upside: +382.85%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $3.10
Upside: +158.06%